From the First Department of Medicine, Osaka University Medical School, Osaka (Received May 22, 1965) Neuropathy is a common complication of diabetes mellitus. The frequent occurrence of neurologic disorders is sometimes regarded as one of the striking features of the disease. It has been noted that clinical lesions of the nervous system occurring in diabetic patients consist chiefly of peripheral neuropathy rather than of central nervous disorders.
In examining these patients, the most frequently complained symptoms of diabetic neuropathy are sensory disturbances such as pain and par -esthesia, and the most consistent objective signs are the abnormality of knee and/or ankle jerk, vibratory perception and motor nerve conduction velocity.
The various theories regarding the pathogenesis of diabetic neuropathy have hitherto been considered.
Several investigators have supposed that the diabetic neuropathy might be due to vascular abnormality, a symptom typical in diabetic patients.
However, metabolic factors are also important. Carbohydrate, especially glucose, has been considered an important energy source in the nervous tissues. Therefore, it is reasonable to believe that the disturbed carbohydrate metabolism observed in diabetics might lead to neuropathy, although the central nervous system could metabolize glucose without insulin.
In connection with this theory, the authors reported that decreased production of C14O2 from glucose-U-C14, increased accumulation of lactate and decreased lipogenesis were observed in in vitro experi -ments using sciatic nerves obtained from rabbits and rats (1, 2) .
Thiamine which is necessary for oxidative reactions in the cells is most frequently used as hydrochloride for the improvement of impaired pyruvate and lactate oxidation observed in diabetics.
The authors used thiamine tetrahydrofur -furyl disulfide, a derivative of thiamine, in the management of neurological mani festations of diabetics who had been treated with insulin or sulfonylurea without any better effect on improvement of neuropathy and obtained considerable relief from subjective symptoms and improvement of patellar reflex and vibratory percep tion (3) .
Recently, coenzyme Q7 (CoQ7) has been found as a carrier of electron transport inside mitochondria.
Shigeta et al. found that the administration of CoQ7 into alloxan diabetic rats showed marked improvement in the decreased C14O2 expiration from glucose-U-C14 (4).
In view of those considerations, it seemed appropriate to determine the possible effectiveness of CoQ7 in the treatment of neuropathy associated with diabetes mellitus.
This report chiefly deals with the clinical observation on CoQ7 treatment in diabetic patients with neuropathy. 
METHODS

RESULTS
Effect of CoQ7 Treatment on Neurological
Abnormalities in Diabetics After CoQ7 treatment with daily oral dose of 10mg for 3 to 13 weeks, 7 of the 14 cases (50%), who had complained of pain, paresthesia and malaise before treatment, showed complete or partial improvement, and none of them showed the 
